Posteromedial Cortex Rhythm Modulation for Dissociative Disorders

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The underlying cellular and circuit mechanisms of dissociative states, such as those observed in dissociative disorders like PTSD and schizophrenia spectrum disorders, remain unknown, leading to ineffective treatments for disrupting normal cognitive processing integration.

Innovation Solution

Modulation of rhythmic neural activity in the posteromedial cortex through agents that target HCN pacemaker channels, NMDA receptors, or monoamine oxidase, using inhibitors or modulators to treat dissociative disorders and induce or suppress dissociative symptoms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If HCN pacemaker channels are inhibited to modulate rhythmic neural activity in the posteromedial cortex, then dissociative symptoms are reduced and therapeutic benefit is achieved, but normal cognitive processing integration may be disrupted

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidcognitive processing disruption
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by modulating the rhythmic neural activity in the posteromedial cortex through HCN channel inhibition. By changing the electrophysiological parameters of neuronal firing patterns (specifically targeting theta-rhythm oscillations), the treatment achieves therapeutic effect while the localized nature of the modulation aims to minimize broader cognitive disruption.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention employs local quality by specifically targeting the posteromedial cortex region for HCN channel inhibition. This localized approach concentrates the therapeutic effect in the brain region most associated with dissociative symptoms, thereby potentially reducing unwanted disruption to other cognitive functions that depend on different brain regions.

Inventive Principle:
Principle #3Local quality

2Reliability

If agents are used to modulate rhythmic neural activity in the posteromedial cortex, then dissociative symptoms are treated, but the underlying cellular and circuit mechanisms remain unknown and difficult to target

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidmechanism understanding
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses HCN pacemaker channels as an intermediary target. Rather than attempting to directly manipulate complex neural circuits or understand all underlying mechanisms, the invention identifies HCN channels as a pharmacologically accessible mediator that influences rhythmic neural activity in the posteromedial cortex, thereby treating dissociative symptoms without requiring complete understanding of all cellular and circuit mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If HCN channel inhibitors are administered to treat dissociative disorders, then therapeutic benefits are achieved for conditions like PTSD and schizophrenia, but selective uncoupling of affective responses from sensory percepts may occur

Engineering Contradiction:
Improvetherapeutic benefitVSAvoidaffective-sensory uncoupling
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies partial action by using HCN channel inhibition to achieve sufficient modulation of rhythmic neural activity in the posteromedial cortex to treat dissociative symptoms, without completely blocking all neural processing. This partial modulation approach aims to restore normal integration of cognitive processing while avoiding excessive suppression that could cause affective-sensory uncoupling.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The proposed methods effectively reduce dissociative symptoms by inhibiting HCN channels or modulating neural activity, providing therapeutic benefits for conditions like PTSD and schizophrenia spectrum disorders.

Implementation Method 1

hyperpolarization-activated cyclic nucleotide-gated (HCN) pacemaker channel

Methodology Applied
Scientific EffectHyperpolarization-activated cyclic nucleotide-gated channel mechanism:

Data Source

PatentUS12582616B2Molecular targets for modulation of dissociative and associative states
Publication Date: 2026.03.24 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US12582616B2 patent drawing
  • US12582616B2 patent drawing
  • US12582616B2 patent drawing

AI summary

Methods of treating a subject for a dissociative disorder and methods of screening agents for the ability to modulate dissociative and associative states in a subject are provided. In particular, agents that alter rhythmic neural activity in the posteromedial cortex can be used to modulate dissociative and associative states in a subject.